WB-IPA convention highlights drug delivery innovations & calls for Pharma Parks to boost industrial growth: Peethaambaran Kunnathoor, Chennai Wednesday, March 25, 2026, 08:00 Hrs ...
AIOCD’s nationwide bandh on May 11 will backfire & strengthen unregulated e-pharmacy business: BDCDA: Nandita Vijayasimha, Bengaluru Wednesday, March 25, 2026, 08:00 Hrs [IST] T ...
Govt on full throttle towards a TB-Mukt Bharat by strengthening multi-sectoral collaboration: Nandita Vijayasimha, Bengaluru Wednesday, March 25, 2026, 08:00 Hrs [IST] Union gover ...
By invoking Rules 62A and 62B of the Drugs and Cosmetics Rules, 1945, the government is considering allowing PACS to operate these centres under Forms 20A and 21A. These specific licenses would permit ...
DGFT restores full RoDTEP benefits for pharma exporters till March 31, 2026: Shardul Nautiyal, Mumbai Wednesday, March 25, 2026, 08:00 Hrs [IST] In a significant move aimed at boo ...
IPA opposes licence to PACS to operate Jan Aushadhi Kendras without pharmacists: Gireesh Babu, New Delhi Wednesday, March 25, 2026, 08:00 Hrs [IST] The Indian Pharmaceutical Assoc ...
Japan MHLW grants marketing authorization to Bayer’s Eylea 8 mg to treat patients with macular edema following RVO: Berlin Tuesday, March 24, 2026, 13:00 Hrs [IST] The Ministry ...
Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing: Zug, Switzerland Tuesday, March 24, 2026, 18:00 Hrs [IST] Galderma, the pure-play d ...
Novartis to present new data on early symptom relief and long-term control in complex skin diseases at AAD 2026: Basel Tuesday, March 24, 2026, 15:00 Hrs [IST] Novartis will prese ...
Japan MHLW grants orphan drug designation to GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan to treat small-cell lung cancer: London, UK Tuesday, March 24, 20 ...
North India’s largest Bone Marrow Transplant Centre inaugurated at ShardaCare-Healthcity by Hon’ble Brajesh Pathak, deputy chief minister and MoHFW: Our Bureau, Mumbai Tuesday ...
Chugai announces Roche to discontinue development of emugrobart in spinal muscular atrophy and FSHD: Tokyo Tuesday, March 24, 2026, 14:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd.